fashion -WSS

fashion

author：fashion 2025-09-27 23:01:35 - browse：1324

Blockchain data -- health tech coverage from STAT — Adobe

This year has seen the Federal Trade Commission crack down on digital health companies’ irresponsible data use. Since February, it has charged four companies with improperly handling sensitive health information — starting with the first-ever enforcement of its long-stagnant Health Breach Notification Rule, against GoodRx.

Now, the FTC is arming itself for even more aggressive enforcement. In June, it proposed changes to the Health Breach Notification Rule that would clarify its ability to regulate digital health companies and their use of health data — filling in some of the gaps left by the patient privacy law HIPAA, which in many cases doesn’t cover the fast-growing world of online and app-based health and wellness services.

“The FTC is seeking to put developers of these kind of apps on notice that they, too, have responsibilities to protect health data,” said Angie Matney, counsel focused on data privacy at the law firm Reed Smith.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Has Bernie Sanders reached the limit of his pharma bullying effort?

entertainment

WSS

Alabama IVF ruling threatens families facing fatal genetic disease

Class action alleges UnitedHealth concealed DOJ probe

In utero gene editing: an explainer

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

A new nitrogen execution bill also undermines medical licensing

As health system earnings go up, health insurance stocks go down

explore

fashion

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Trump demands the U.S. pay no more for drugs than other countries … again

Chemotherapy before breast cancer surgery might fuel metastasis

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

How one medical school became remarkably diverse

6 phony surgeries that take placebo to the extreme

Moonlake's readout produced a cash windfall. Risks remain

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Wikipedia

Class action alleges UnitedHealth concealed DOJ probe

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Sepsis can kill a child within hours. Here's how hospitals are fighting back

With competition flaring, obesity drug hits goal in liver disease study

Antivenom research: Lessons from HIV applied in search for universal antidote

Chemotherapy before breast cancer surgery might fuel metastasis

entertainment

explore

explore

leisure time